2025-03-29 03:25:36
Latest Post
Unifinz Capital India Limited declares interim dividend of Rs. 0.50
Suprajit Completes Second Tranche of SCS Acquisition
Ceigall Ayodhya Bypass Pvt Ltd receives appointed date from NHAI
Lemon Tree Hotels signs a new property in Maharashtra
Karur Vysya Bank inaugurates 4 new branches today, 3 in TN and 1 in AP
Stock Report
Genomic Valley Biotech Ltd Q2 FY2025 PAT at Rs. 14.75 lakhs
Posted On : 2024-10-07 23:16:38( TIMEZONE : IST )
Genomic Valley Biotech Ltd has reported Standalone financial results for the period ended September 30, 2024.
Financial Results (Q2 FY2025) - QoQ Comparison
The company has reported total income of Rs. 0.2122 crores during the period ended September 30, 2024 as compared to Rs. 0.1553 crores during the period ended June 30, 2024.
The company has posted net profit / (loss) of Rs. 0.1475 crores for the period ended September 30, 2024 as against net profit / (loss) of Rs. 0.1275 crores for the period ended June 30, 2024.
The company has reported EPS of Rs. 0.48 for the period ended September 30, 2024 as compared to Rs. 0.42 for the period ended June 30, 2024.
| Financials | Q2 FY2025 | Q1 FY2025 | % Change |
| Total Income | ₹0.2122 crs | ₹0.1553 crs |  36.64% |
| Net Profit | ₹0.1475 crs | ₹0.1275 crs | 15.69% |
| EPS | ₹0.48 | ₹0.42 | 14.29% |
Financial Results (Q2 FY2025) - YoY Comparison
The company has reported total income of Rs.0.2122 crores during the period ended September 30, 2024 as compared to Rs.0.0675 crores during the period ended September 30, 2023.
The company has posted net profit / (loss) of Rs.0.1475 crores for the period ended September 30, 2024 as against net profit / (loss) of Rs.0.0232 crores for the period ended September 30, 2023.
The company has reported EPS of Rs.0.48 for the period ended September 30, 2024 as compared to Rs.0.08 for the period ended September 30, 2023.
| Financials | Q2 FY2025 | Q2 FY2024 | % Change |
| Total Income | ₹0.2122 crs | ₹0.0675 crs | 214.37% |
| Net Profit | ₹0.1475 crs | ₹0.0232 crs | 535.78% |
| EPS | ₹0.48 | ₹0.08 | 500.00% |
Financial Results (Half Year Ended FY2025) - YoY Comparison
The company has reported total income of Rs.0.3675 crores during the 6 Months period ended September 30, 2024 as compared to Rs.0.1275 crores during the 6 Months period ended September 30, 2023.
The company has posted net profit / (loss) of Rs.0.2751 crores for the 6 Months period ended September 30, 2024 as against net profit / (loss) of Rs.0.05 crores for the 6 Months period ended September 30, 2023.
The company has reported EPS of Rs.0.90 for the 6 Months period ended September 30, 2024 as compared to Rs.0.16 for the 6 Months period ended September 30, 2023.
| Financials | Half Year Ended FY2025 | Half Year Ended FY2024 | % Change |
| Total Income | ₹0.3675 crs | ₹0.1275 crs | 188.24% |
| Net Profit | ₹0.2751 crs | ₹0.05 crs | 450.20% |
| EPS | ₹0.90 | ₹0.16 | 462.50% |
Shares of Genomic Valley Biotech Ltd was last trading in BSE at Rs. 82.10 as compared to the previous close of Rs. 80.50. The total number of shares traded during the day was 6613 in over 46 trades.
The stock hit an intraday high of Rs. 82.10 and intraday low of 80.00. The net turnover during the day was Rs. 541274.00.
